Cargando…
Revisiting the public health implications of the United States–Mexico– Canada agreement
This commentary re-examines a recent article by Labonté et al on the recent changes to two relevant provisions relating to patent rights in the final version of the United-States-Mexico-Canada Agreement (USMCA). Although the USMCA’s final revised version does not add more pharmaceutical patent prote...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275535/ https://www.ncbi.nlm.nih.gov/pubmed/32503571 http://dx.doi.org/10.1186/s12992-020-00579-y |